Fred McElwee
MA, MSc
DPhil Student
Fred is a doctoral student within the Health Economics Research Centre (HERC), under the supervision of Prof. Sarah Wordsworth, Dr. Padraig Dixon, and Dr. Nicky Wiffen.
He previously read the MA Economics at the University of Edinburgh and the MSc Global Health Science and Epidemiology at the University of Oxford, after which he worked as an Economist at the Office of Health Economics, a leading health economics research organisation. Since joining HERC in 2024, his focus has shifted to genomic health economics, including economic evaluation of genomic sequencing.
Fred is passionate about ensuring that health-improving medical innovations are accessible to patients, and his mission is to lead impactful research at the intersection of genomics, health economics, and decision science. His DPhil project aims to identify and analyse challenges around reimbursement of genome-targeted therapies such as CRISPR gene editing and antisense oligonucleotides (ASOs). He also aims to demonstrate when and how these challenges can be overcome to facilitate timely patient access in a way that is consistent with health system aims like maximising population health.
Fred is grateful to be supported in his studies by a full scholarship from the Clarendon Fund, the Brasenose Clarendon Award, and a Department of Population Health Studentship.
Recent publications
-
Alternative Payment Models for Innovative Medicines: A Framework for Effective Implementation
McElwee F. et al, (2025), Applied Health Economics and Health Policy
-
The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment.
McElwee F. and Newall A., (2024), Pharmacoeconomics
-
HPR116 Is Payment Innovation Keeping Up With Therapy Innovation? A New Taxonomy of Innovative Payment Solutions to Aid Effective Implementation
McElwee F. et al, (2023), Value in Health, 26, S274 - S274